DK1942891T3 - Ny kombination af lægemidler som antidepressivt middel - Google Patents

Ny kombination af lægemidler som antidepressivt middel

Info

Publication number
DK1942891T3
DK1942891T3 DK06798441.9T DK06798441T DK1942891T3 DK 1942891 T3 DK1942891 T3 DK 1942891T3 DK 06798441 T DK06798441 T DK 06798441T DK 1942891 T3 DK1942891 T3 DK 1942891T3
Authority
DK
Denmark
Prior art keywords
antidepressant
drugs
new combination
new
combination
Prior art date
Application number
DK06798441.9T
Other languages
English (en)
Inventor
Kazuo Sakai
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of DK1942891T3 publication Critical patent/DK1942891T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06798441.9T 2005-09-22 2006-09-22 Ny kombination af lægemidler som antidepressivt middel DK1942891T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005276222 2005-09-22
PCT/JP2006/319393 WO2007034990A1 (en) 2005-09-22 2006-09-22 Novel combination of drugs as antidepressant

Publications (1)

Publication Number Publication Date
DK1942891T3 true DK1942891T3 (da) 2011-04-26

Family

ID=37441728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06798441.9T DK1942891T3 (da) 2005-09-22 2006-09-22 Ny kombination af lægemidler som antidepressivt middel

Country Status (12)

Country Link
EP (1) EP1942891B1 (da)
JP (1) JP5015159B2 (da)
CY (1) CY1112216T1 (da)
DE (1) DE602006020900D1 (da)
DK (1) DK1942891T3 (da)
ES (1) ES2362926T3 (da)
HR (1) HRP20110225T1 (da)
PL (1) PL1942891T3 (da)
PT (1) PT1942891E (da)
RS (1) RS51669B (da)
SI (1) SI1942891T1 (da)
WO (1) WO2007034990A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008019431A1 (en) * 2006-08-14 2008-02-21 Brc Operations Pty Limited Method and compositions for simultaneously regulating memory and mood
TR201001117A1 (tr) 2010-02-15 2011-09-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Dimebolin ve memantin kombinasyonları
CN108147827A (zh) * 2018-01-12 2018-06-12 安徽海螺暹罗耐火材料有限公司 一种碱性耐火材料用结合剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
JP2007523121A (ja) * 2004-02-19 2007-08-16 ノバルティス アクチエンゲゼルシャフト 血管性鬱病の処置のためのコリンエステラーゼ阻害剤の使用

Also Published As

Publication number Publication date
EP1942891B1 (en) 2011-03-23
WO2007034990A1 (en) 2007-03-29
SI1942891T1 (sl) 2011-06-30
HRP20110225T1 (hr) 2011-04-30
RS51669B (en) 2011-10-31
PT1942891E (pt) 2011-06-27
ES2362926T3 (es) 2011-07-15
JP5015159B2 (ja) 2012-08-29
EP1942891A1 (en) 2008-07-16
CY1112216T1 (el) 2015-12-09
PL1942891T3 (pl) 2011-08-31
JP2009508849A (ja) 2009-03-05
DE602006020900D1 (de) 2011-05-05

Similar Documents

Publication Publication Date Title
NO20200301A1 (no) Ny formulering
DK2010498T3 (da) Syntese af acylaminoalkenylenamider, der kan anvendes som substans P-antagonister
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1940465T3 (da) Ny anvendelse af anti-IL-1beta-antistoffer
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK1879844T3 (da) Fremstilling af natriumdiformiat
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
DK2425715T3 (da) Behandling af symptomer på nyresygdom med selektive, androgenreceptor modulatorer (SARM)
DK1656345T3 (da) Cykliske derivater som modulatorer af chemokinreceptoraktivitet
DK1735286T3 (da) Tetrahydroindazoler som cannabinoidmodulatorer
DK1915346T3 (da) Asymmetrisk katalytisk reduktion af oxcarbazepin
DK3225251T3 (da) Modulering af pro-neurotrofinaktivitet
DK2004610T3 (da) Fremstilling af eslicarbazepin og beslægtede forbindelser ved asymmetrisk hydrogenering
DK1931315T3 (da) Depotformuleringer af nalbufin
DK1917227T3 (da) Krystalformer af astaxanthin
DK1991529T3 (da) Substituerede arylsulfonamider som antivirale midler
DK1986622T3 (da) Små-molekyle-modulatorer af Trp-p8-aktivitet
DK2167124T3 (da) Anvendelse af monomycolylglycerol (MMG) som adjuvans
DK2049519T3 (da) Cykliske derivater som modulatorer af chemokinreceptoraktivitet
NO20043305D0 (no) Preparation of lodixanol
NO20055643D0 (no) Preparation of lodixanol
DK2054363T3 (da) Asymmetrisk hydrogenering af 1,1,1-trifluoracetone
DK2121138T3 (da) Terapeutiske anvendelser af eslicarbazepin